Journal of Cardiac Surgery · 2013 · 85 citations · 28 references
MedicineCardiologySurgeryCardiac TransplantationCardiothoracic SurgeryHemodynamic ManagementCardiopulmonary BypassHeart FailureHeart TransplantationPulmonary HypertensionThoracic SurgeryTricuspid RegurgitationEnd-stage Heart Failure CareLeft Ventricular Assist Device TherapyLeft Ventricular Assist DevicesPulmonary Arterial PressurePulmonary Artery Pressure MeasurementRight Ventricular ContractilitySurgical Tricuspid Valve RepairSurgical Tricuspid Valve Replacement
BACKGROUND: Continuous flow left ventricular assist devices (CF LVAD) are being implanted with increasing frequency for end-stage heart failure. At the time of LVAD implant, a large proportion of patients have pulmonary hypertension, right ventricular (RV) dysfunction, and tricuspid regurgitation (TR). RV dysfunction and TR can exacerbate renal dysfunction, hepatic dysfunction, coagulopathy, edema, and even prohibit isolated LVAD implant. Repairing TR mandates increased cardiopulmonary bypass time and bicaval cannulation, which should be reserved for the time of orthotopic heart transplantation. We hypothesized that CF LVAD implant would improve pulmonary artery pressures, enhance RV function, and minimize TR, obviating need for surgical tricuspid repair. METHODS: One hundred fourteen continuous flow LVADs implanted from 2005 through 2011 at a single center, with medical management of functional TR, were retrospectively analyzed. Pulmonary artery pressures were measured immediately prior to and following LVAD implant. RV function and TR were graded according to standard echocardiographic criteria, prior to, immediately following, and long-term following LVAD. RESULTS: There was a significant improvement in post-VAD mean pulmonary arterial pressures (26.6 ± 4.9 vs. 30.2 ± 7.4 mmHg, p = 0.008) with equivalent loading pressures (CVP = 12.0 ± 4.0 vs. 12.1 ± 5.1 p = NS). RV function significantly improved, as noted by right ventricular stroke work index (7.04 ± 2.60 vs. 6.05 ± 2.54, p = 0.02). There was an immediate improvement in TR grade and RV function following LVAD implant, which was sustained long term. CONCLUSION: Continuous flow LVAD implant improves pulmonary hypertension, RV function, and tricuspid regurgitation. TR may be managed nonoperatively during CF LVAD implant.
28
Use of a Continuous-Flow Device in Patients Awaiting Heart Transplantation
Leslie W. Miller, Francis D. Pagani, Stuart D. Russell et al. · New England Journal of Medicine · 2007 · 1.7K citations · Full text
Medicine, Cardiology, Surgery +16
Robert L. Kormos, Jeffrey J. Teuteberg, Francis D. Pagani et al. · Journal of Thoracic and Cardiovascular Surgery · 2010 · 931 citations · Full text
Medicine, Cardiology, Surgery +15